Net sales surged year-over-year, driven by Ivisys, but Q3 saw a negative operating result due to security value declines and one-off costs. Board proposes a major share redemption and plans to delist, while maintaining strong liquidity and focusing on Ivisys growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.